Mount-Sinai-2nd-International-Prostate-Cancer-Symposium-Final-Prospectus

EXHIBITOR AND PROMOTIONAL Second International Prostate Cancer Symposium and Inaugural World Congress of Urologic Oncology PARTNERSHIP PROSPECTUS SEPTEMBER 7-9 MOUNT SINAI HOSPITAL NEW YORK, NEW YORK 2017 In Collaboration With: HIGHLIGHTS • Over 100 renowned global faculty • Live 3D surgical demonstrations, including prostate, kidney, bladder and reconstruction • Point-Counterpoint Debate • Annual Push Up Challenge • Gala to Raise Funds for Urologic Cancer Research TOPIC AREAS • Screening and Low Risk Disease • Biomarkers and Genomics • Immunotherapy • Focal Therapy • Localized Prostate Cancer • Advanced Prostate Cancer • Kidney Cancer • Bladder Cancer www.mountsinaiurologycme.org Invitation to Exhibit/Sponsor Course Director Ash Tewari, MBBS, MCh Co-Director Ketan K Badani, MD Associate Directors Nina Bhardwaj, MD, PhD Carlos Cordon-Cardo, MD, PhD William Oh, MD Site Directors Mantu Gupta, MD Michael A Palese, MD Dear Industry Colleagues: On behalf of the Department of Urology at the Icahn School of Medicine at Mount Sinai in New York City, I would like to invite you to partner with the Second International Prostate Cancer Symposium and Inaugural World Congress of Urologic Oncology being held on September 7-9, 2017 at Mount Sinai Hospital in New York in affiliation with the Society of Urologic Robotic Surgeons and Endourological Society Ranked among the nation’s best for Urology in the 2016-2017 "Best Hospitals" issue of U.S News & World Report, the physicians of Mount Sinai Urology Associates are leaders in robotic surgery and minimally invasive procedures to treat prostate, kidney, and bladder cancers The Mount Sinai Urology team is also on the forefront of diagnosis and treatment for urinary tract and prostate disorders, erectile dysfunction, kidney stones, infertility, female pelvic medicine and pediatric urologic conditions Join us for an interactive symposium with 3D demonstrations of the latest robotic surgery techniques for prostate, kidney and bladder cancer and reconstruction Directed by the world’s leading robotic experts and taught by an internationally renowned faculty, attendees will gain emerging and practical tools to optimize their robotic surgical skills Additional highlights include sessions on immunotherapy, focal therapy, advanced disease, point-counterpoint debates and a kick-off, inaugural address by Dennis Charney, MD, Dean of the Icahn School of Medicine at Mount Sinai Affiliating with the Second International Prostate Cancer Symposium and Inaugural World Congress of Urologic Oncology is the most direct route in meeting with and sharing your products with some of the most well-known and respected health care providers and decision makers in the urological community As an essential part of the symposium, you will be able to place your product in the hands of key opinion leaders in the field and encourage new and existing relationships Please review the 2017 Partnership Prospectus and reserve your prime exhibit space today to participate in this cutting-edge urologic oncology conference We look forward to having you as our industry partner More information can be found at Mountsinaiurologycme.org or if you have questions please contact Meredith Wolff at (917) 301-6169 or via email at meredith.wolff@mountsinai.org Sincerely, Ash Tewari, MD System Chairman, Department of Urology Professor of Urology Academic Office: Icahn School of Medicine at Mount Sinai 1425 Madison Avenue, 6th Floor | New York, NY 10029 Telephone: 212.241.8971 | Email: ash.tewari@mountsinai.org NON-CME Diamond Jubilee celebration –75 years of Urology at Mount Sinai WED SEPTEMBER 11AM - 5PM Push Up for Prostate Cancer Challenge DEAN AND CHAIRS WELCOME LAST 75 YEARS JOURNEY Michael Droller HIGHLIGHTS Pediatric Urology Jeffrey Stock • Men’s Health Program Steven A Kaplan Sexual Medicine Robert Valenzuela • Reconstructive Urology Rajveer Purohit Immunotherapy Simon Hall • Robotic Surgery Ketan Badani • Stone Center Mantu Gupta Precision Urology Michael Donovan • Intervention Urology Ardeshir Rastinehad PRESENTATIONS ALSO BEING GIVEN BY Carl Olsson • Alex Kirschenbaum • Nihal Mohamed • Sujit Nair Kamlesh Yadav • Shalini Singh Yadav • John Griffith • Peter Wiklund Michael Palese • Hugh Lavery • Howard Schiff Screening & Low Risk Disease THURSDAY SESSION I Ronney Abaza, MD Ohio Health Dublin Methodist Hospital USA GENERAL SESSION Thomas Ahlering, MD Ketan Badani, MD University of California Irvine Icahn School of Medicine School of Medicine at Mount Sinai USA USA TOPIC AREAS Giuseppe Carrieri, MD University of Foggia Italy Peter Carroll, MD, MPH University of California San Francisco USA Mark Emberton MD, FRCS University College United Kingdom Leonard Gomella, MD Thomas Jefferson University Hospital USA James Gulley, MD, PhD National Cancer Institute National Institutes of Health USA Alexander Haese, MD The Martini-Clinic Prostate Cancer Center Germany Kenneth Haines, MD Icahn School of Medicine at Mount Sinai USA Michael Herman, MD Icahn School of Medicine at Mount Sinai USA Jim Hu, MD, PhD Weill Cornell USA Eric Klein, MD Cleveland Clinic USA Badrinath Konety MD, FACS, MBA University of Minnesota USA Manoj Monga, MD Cleveland Clinic USA Lorelei Mucci, MPH, ScD Harvard School of Public Health USA Aria Olumi, MD Massachuets General Hospital USA Michael Palese, MD Icahn School of Medicine at Mount Sinai USA Ardeshir Rastinehad, DO Icahn School of Medicine at Mount Sinai USA Fritz Schröder, MD, PhD Erasmus University Medical Center Netherlands Ash Tewari MD, MBBS, Mch Medicine at Mount Sinai USA Vipul Patel, MD Christopher Porter, MD, FACS Florida Hospital Virginia Mason Medical Center Global Robotics Institute USA USA Patrick Walsh, MD The Johns Hopkins School of Medicine TOPIC AREAS Focal Therapy THURSDAY SESSION II Mark Emberton MD, FRCS University College United Kingdom GENERAL SESSION Herbert Lepor, MD New York University Langone Medical Center USA Nelson Stone, MD Icahn School of Medicine at Mount Sinai USA Dipen Parekh, MD University of Miami Miller School of Medicine USA Bachir Taouli, MD Icahn School of Medicine at Mount Sinai USA Ardeshir Rastinehad, DO Icahn School of Medicine at Mount Sinai USA Arnauld Villers, MD, PhD University of Lille France Peter Schulam, MD, PhD Yale School of Medicine USA Jorn Witt, MD St Antonius-Hospital Germany Treatment Failure THURSDAY SESSION III GENERAL SESSION Ketan Badani, MD Icahn School of Medicine at Mount Sinai USA Axel Heidenreich, MD Universitätsklinikum Kölnzertifiziertes Prostatazentrum Germany Brian Chapin, MD MD Anderson Cancer Center USA Michael Cookson, MD The University of Oklahoma USA Aaron Katz, MD, FACS Winthrop University Hospital USA John Davis, MD, FACS MD Anderson Cancer Center USA Vipul Patel, MD Florida Hospital Global Robotics Institute USA TOPIC Immunotherapy & Tumor Microenvironment THURSDAY SESSION I BREAKOUT SESSION AREAS Nina Bhardwaj, MD, PhD Icahn School of Medicine at Mount Sinai USA Matthew Galsky, MD Icahn School of Medicine at Mount Sinai USA Sacha Gnjatic, PhD Icahn School of Medicine at Mount Sinai USA Isuru Jayaratna, MD Icahn School of Medicine at Mount Sinai USA Susan Slovin, MD, PhD Memorial Sloan Kettering Cancer Center USA Ash Tewari, MD, MBBS, Mch Icahn School of Medicine at Mount Sinai USA RADICAL PROSTATECTOMY FRIDAY SESSION I TOPIC AREAS GENERAL SESSION Thomas Ahlering, MD University of California Irvine School of Medicine USA David Albala, MD Crouse Hospital, Syracuse USA Thomas Bessede, MD Hopital Bicetre-APHP France Fabrizio Dal Moro, MD University of Padova Italy John Davis, MD, FACS MD Anderson Cancer Center USA Inderbir Gill, MD USC Urology USA Ashok Hemal MD, MCh, FACS, FRCS Wake Forest Baptist Health USA Jean Joseph, MD, MBA University of Rochester Medical Center USA Jihad Kaouk, MD Cleveland Clinic USA John Libertino, MD Emerson Hospital USA Mani Menon, MD Henry Ford Health System USA Dipen Parekh, MD University of Miami Miller School of Medicine USA Vipul Patel, MD Florida Hospital Global Robotics Institute USA Francesco Porpiglia, MD University of Turin Italy Atsushi Takenaka, MD, PhD University of Minnesota USA Ash Tewari, MD, MBBS, Mch Icahn School of Medicine at Mount Sinai USA TREATING LOCALIZED DISEASE FRIDAY SESSION II GENERAL SESSION TOPIC AREAS Ketan Badani, MD Icahn School of Medicine at Mount Sinai USA Jean Joseph, MD, MBA University of Rochester Medical Center USA Rakesh Kapoor, MBBS, MCh Sanjay Gandhi Post Graduate Institute of Medical Sciences India Aaron Katz, MD, FACS Winthrop University Hospital USA Deepak Kapoor, MD Advanced Urology Centers of New York USA Mani Menon, MD Henry Ford Health System USA Craig Nobert, MD Icahn School of Medicine at Mount Sinai USA Francesco Porpiglia, MD University of Turin Italy Isaac Powell, MD Wayne State Univertsity USA Prasanna Sooriakumaran MBBS, PhD Manor Hospital Oxford United Kingdom Richard Stock, MD Icahn School of Medicine at Mount Sinai USA James Porter, MD Swedish Medical Center USA Ash Tewari, MD, MBBS, Mch Icahn School of Medicine at Mount Sinai USA Michael Zelefsky, MD Memorial Sloan Kettering Cancer Center USA TOPIC AREAS ADVANCED PROSTATE CANCER FRIDAY SESSION III MAIN ROOM Carlos Cordon-Cardo MD, PhD Icahn School of Medicine at Mount Sinai USA Vincent Laudone, MD Memorial Sloan Kettering Cancer Center USA Matthew Galsky, MD Icahn School of Medicine at Mount Sinai USA Bobby Liaw, MD Icahn School of Medicine at Mount Sinai USA Ramon Parsons, MD, PhD Icahn School of Medicine at Mount Sinai USA Eric Schadt, MD Icahn School of Medicine at Mount Sinai USA Philip Kantoff, MD Memorial Sloan Kettering Cancer Center USA William Oh, MD Icahn School of Medicine at Mount Sinai USA Daniel Petrylak, MD Yale School of Medicine USA Jonathan Simons, MD Milken Institute USA Ganesh Palapattu, MD University of Michigan USA Kenneth Pienta MD The Johns Hopkins USA Howard Soule, MD Milken Institute USA TOPIC AREAS Locally Advanced Disease FRIDAY SESSION I BREAKOUT SESSION Brian Chapin, MD MD Anderson Cancer Center USA Ronald Ennis, MD Icahn School of Medicine at Mount Sinai USA Jonathan Haas, MD Winthrop University Hospital USA Markus Hohenfellner, MD University of Heidelberg Germany Richard Stock, MD Icahn School of Medicine at Mount Sinai USA Michael Zelefsky, MD Memorial Sloan Kettering Cancer Center USA Shawn Zimberg, MD Good Samaritan Regional Medical Center USA Kenneth Rosenzweig, MD Icahn School of Medicine at Mount Sinai USA Quality of Life FRIDAY SESSION II BREAKOUT SESSION Natan Bar-Chama, MD Icahn School of Medicine at Mount Sinai USA Jerry Blaivas, MD New York-Presbyterian USA Philippa Cheetham, MD Icahn School of Medicine at Mount Sinai USA Vincenzo Ficarra, MD University of Udinese Italy Daniel Gainsburg, MD Icahn School of Medicine at Mount Sinai USA Neil Grafstein, MD Icahn School of Medicine at Mount Sinai USA Steve Kaplan, MD Icahn School of Medicine at Mount Sinai USA Jeffrey I Mechanick, MD Icahn School of Medicine at Mount Sinai USA Victor Nitti, MD New York University Langone Medical Center USA Rajveer Purohit, MD Weill Cornell USA Robert Valenzuela, MD Icahn School of Medicine at Mount Sinai USA 18 SYMPOSIUM AGENDA *Please Note, agenda is subject to change For the most updated symposium agenda please visit our website at: www.mountsinaiurologycme.org DAY - Wednesday, September GENERAL SESSION - STERN AUDITORIUM 1:15-1:45 The Push Up Challenge 1:45-2:00 Welcome Message From The Dean Welcome and Department Chair 2:00-2:20 The 75th Edition: Our Journey and Achievements Michael Droller, MD 2:20-2:30 A New Prostate Biopsy Reporting System with Prognostic Potential Carl Olsson, MD 2:30-2:40 Oligometastatic Prostate Cancer Alex Kirschenbaum, MD 2:40-2:55 Stone Center Mantu Gupta, MD 2:55-3:10 Men’s Health Program Steven A Kaplan, MD 3:10-3:25 Sexual Medicine Robert Valenzuela, MD 3:25-3:40 Reconstructive Urology Rajveer Purohit, MD 3:40-3:55 Intervention Urology Ardeshir Rastinehad, DO 3:55-4:10 Robotic Surgery Ketan Badani, MD 4:10-4:25 Pediatric Urology Jefferey Stock, MD 4:25-4:40 Precision Urology Michael Donovan MD, PhD 4:40-4:55 Immunotherapy Simon Hall, MD 4:55-5:10 Behavioral Research Nihal Mohamed, PhD 5:10-5:15 New Adjuvant Platforms For Immunotherapy Sujit Nair, PhD 19 DAY - Wednesday, September 5:15-5:20 Abdominal Inflammation and Prostate Cancer Kamlesh Yadav, PhD 5:20-5:25 Resident Lecture John Griffiths, MD 5:25-5:30 Close of Meeting Ash Tewari, MBBS, MCh 20 DAY - Thursday, September STERN AUDITORIUM 7:20-7:30 Introduction Ash Tewari, MBBS, MCh SESSION I SCREENING & LOW RISK DISEASE Moderator: Peter Carroll, MD, MPH 7:30-8:00 How Nerve Sparing Changed the Outcome of Prostate Cancer Patrick Walsh, MD 8:00-9:00 Live Surgery Surgeon: Ash Tewari, MD Moderator: Ketan Badani, MD Panel: Thomas Ahlering, MD, Giuseppe Carrieri, MD, Michael Palese, MD 9:00-9:10 Epidemiology Lorelei Mucci, MPH, ScD 9:10-9:25 Screening For Prostate Cancer Fritz Schröder, MD 9:25-9:40 USPTF Recommendations Jim Hu, MD, MPH 9:40-10:00 Genomic Complexity of Prostate Cancer Ash Tewari, MBBS, MCh 10:00-10:20 Immunotherapy in Prostate Cancer James Gulley, MD, PhD 10:20-10:40 BREAK / VISIT EXHIBITS 10:40-11:00 Emerging Role of MRI for Screening Ash Tewari, MBBS, MCh 11:00-11:15 Emerging Role of Genomics Leonard Gomella, MD 11:15-11:25 Novel Biomarkers Badrinath Konety, MD 11:25-11:40 Active Surveillance Peter Carroll MD, MPH 11:40-12:00 Debate: Genomics vs MRI in Risk Stratification Moderator: Peter Carroll MD, MPH Genomics: Eric Klein, MD MRI: Ardeshir Rastinehad, DO 12:00-1:00 LUNCH BREAK / LUNCH SYMPOSIUM 21 DAY - Thursday, September 1:00-2:00 Live Surgery Surgeon: Ash Tewari, MD Moderator: Vip Patel, MD Panel: Michael Herman, MD, Christopher Porter, MD, Ronney Abaza, MD SESSION II FOCAL THERAPY Moderator: Jorn Witt, MD 2:00-2:15 Prostate MRI: What Urologists Should Know Bachir Taouli, MD 2:15-2:25 3D Mapping Biopsy Nelson Stone, MD 2:25-2:40 Fusion Biopsy: Current Status and Future Directions Peter Schulam, MD, PhD 2:40-2:50 Focal Therapy & Index Lesion Dipen Parekh, MD 2:50-3:00 Focal Therapy: Is it ready for prime time? Herbert Lepor, MD 3:00-3:10 HIFU Dipen Parekh, MD 3:10-3:20 Gold Nanoparticle Treatment Ardeshir Rastinehad, DO 3:20-3:40 BREAK / VISIT EXHIBITS SESSION III TREATMENT OF RECURRENCE Moderator: John Davis, MD, FACS 3:40-3:50 Prevention of Positive Margins and BCR: Neurosafe Alexander Haese, MD 3:50-4:00 Neurosafe: US Experience Kenneth Haines, MD 4:00-4:15 Importance of Surgical Margins & Biochemical Failure Michael Cookson, MD 4:15-4:25 Adjuvant vs Salvage Treatment Post Radical Prostatectomy John Davis, MD, FACS 4:25-4:35 Role of Salvage LND in Recurrence Thomas Ahlering, MD 22 DAY - Thursday, September 4:35-4:45 Focal Therapy Failure Arnauld Villers MD, PhD 4:45-5:05 Debate: Radiotherapy Failure: Salvage RALP vs Cryotherapy Moderator: Ketan Badani, MD RALP: Vip Patel, MD Cryotherapy: Aaron Katz, MD, FACS 5:05-5:15 Best Poster Award BREAKOUT ROOM – Annenburg, 5th Floor SESSION I IMMUNOTHERAPY & TUMOR MICROENVIRONMENT Moderators: Nina Bhardwaj 1:00-1:15 Dendritic Vaccine platforms for Cancer Immunotherapy Oncogenomics and Neo-antigen Discovery Nina Bhardwaj, MD, PhD 1:15-1:30 Standard of Care and Combination Immunotherapy: Understanding Therapeutic Synergy Matthew Galsky, MD 1:30-1:45 Tumor Microenvironment and Immuno-engineering Ankur Singh, PhD 1:45-2:00 High Throughput Phip-Seq And Phase Display SystemApplications In Cancer Research And Immunotherapy Uri Laserson, PhD 2:00-2:15 Biomarkers and Immunotherapy Susan F Slovin, MD, PhD 2:15-2:30 Next Generation Platforms for Immune Monitoring Sacha Gnjatic, PhD 2:30-2:45 Success of ImmunotherapyLessons learned from Inflamed and Noninflamed cancers Ash Tewari, MBBS, MCh 2:45-3:00 Research Discovery And Preclinical Development Of Immunotherapy Drugs Robert Stein, PhD 3:00-3:15 Immuno-Oncology’s Signal-to-Noise Problem: Developing Proof of Relevance for Novel MOAs Jeffrey M Bockman, MD 3:15-3:30 BREAK / VISIT EXHIBITS 23 DAY - Thursday, September SESSION II BASIC SCIENCE SESSION Moderators: Joseph Domingo-Domenech, David Mulholland, Kamlesh Yadav, Veronica Rodriguez-Bravo, Shalini Singh-Yadav 3:30-3:45 Targetable Mechanisms Of Aggressiveness In Lethal Prostate Cancer Josep Domingo-Domenech, MD, PhD 3:45-4:00 Patient-centered Outcomes in Urologic Care: Limitations and Potential Solutions Nihal Mohamed, PhD 4:00-4:15 Genome Integrity Maintenance Mechanisms In Prostate Cancer Veronica Rodriguez-Bravo, PhD 4:15-4:30 Tumor Heterogeneity in Prostate and Kidney Cancer Shalini Singh Yadav, PhD 4:30-4:45 Targeting Castration Resistant Metastatic Prostate Cancer With A Novel Glycolytic Pathway Inhibitor Yixuan Gong, PhD 4:45-5:00 Novel Therapeutic Strategies for Neuroendocine Prostate Cancer Kamlesh Yadav, PhD 5:00-5:15 PI3K/PTEN Pathway Can Present A Vulnerability Of Prostate Cancer Sait Ozturk, PhD 5:15-5:30 Advanced Diffusion-Weighted Imaging Of Prostate Cancer: Correlation With Quantitative Histopathology Stephanie Hectors, PhD 5:30-5:45 Mechanism-Based Studies To Elucidate The Role Of Tumor Antigens In Prostate Cancer Sujit Nair, PhD 24 DAY - Friday, September STERN AUDITORIUM SESSION I RADICAL PROSTATECTOMY Moderator: David Albala, MD, Inderbir Gill, MD 7:00-7:10 Surgical Anatomy of Prostate Atsushi Takenaka, MD 7:10-7:20 Neural Supply of the Male Urethral Sphincter Thomas Bessede, MD 7:20-7:40 Foundations of Anatomic RALP - Continence Ash Tewari, MBBS, MCh 7:40-7:50 Radical Prostatectomy Technique For Preservation of Urinary Continence and The Pagano Suture John Libertino, MD 7:50-8:00 Nerve Sparing Techniques Vip Patel, MD 8:00-9:00 Live Surgery Surgeon: Ash Tewari, MD Moderator: Thomas Ahlering, MD Panel: Dipen Parekh, MD, John Davis, MD, FACS, Francesco Porpiglia, MD 9:00-9:10 Strategies To Manage Trifecta In Robotic Prostate Cancer Surgery David Lee, MD 9:10-9:20 Robot Assisted Partial Prostatectomy Inderbir Gill, MD 9:20-9:30 3D Imaging and Treatment Planning Francesco Porpiglia, MD 9:30-9:40 Newer techniques in RARP/Fluorescent Guided Surgery Ashok Hemal, MD 9:40-9:50 Pelvic LND for prostate cancer - Worth the Full Effort or Skip? John Davis, MD, FCAS 9:50-10:00 Extraperitoneal Radical Prostatectomy Jean Joseph, MD 10:00-10:10 Perineal Radical Prostatectomy Jihad Kaouk, MD 10:10-10:20 "Art" of Radical Prostatectomy Fabrizio Dal Moro, MD 25 DAY - Friday, September 10:20-10:40 Journey of Robotic Surgery Mani Menon, MD 10:40-11:00 BREAK / VISIT EXHIBITS SESSION II TREATING LOCALIZED DISEASE Moderator: Rakesh Kapoor, MD 11:00-11:10 Active Surveillance Deepak Kapoor, MD 11:10-11:20 Brachytherapy Richard Stock, MD 11:20-11:30 Focal Therapy Aaron Katz, MD, FACS 11:30-11:40 Radical Prostatectomy Prasanna Sooriakumaran, MD, PhD 11:40-11:50 Radiotherapy Michael Zelefsky, MD 11:50-12:05 Debate: Best method to treat high risk cancer Moderator: Francesco Porpiglia, MD Radical Prostatectomy: Prasanna Sooriakumaran, MD, PhD Radiotherapy: Michael Zelefsky, MD 12:05-12:20 Debate: Best method to treat low risk cancer Moderator: Ketan Badani, MD Focal Therapy: Aaron Katz, MD, FACS Active Surveillance: Deepak Kapoor, MD 12:20-1:20 LUNCH BREAK / LUNCH SYMPOSIUM 1:20-1:50 Anatomical Foundations of RP – Nerve Sparing Ash Tewari, MBBS, MCh 1:50-2:50 Live Surgery Surgeon: Ash Tewari, MD Moderator: Mani Menon, MD Panel: Craig Nobert, MD, Prasanna Sooriakumaran, MD, PhD, Jim Porter, MD, Jean Joseph, MD SESSION III ADVANCED PROSTATE CANCER Moderator: Bobby Liaw, MD 2:50-3:05 Disseminated Tumor Cells at the Time of Radical Prostatectomy What is the real incidence? Kenneth Pienta, MD 26 DAY - Friday, September 3:05-3:15 Functional Genomics Eric Schadt, PhD 3:15-3:25 PTEN Signaling and Metabolism Ramon Parsons, MD, PhD 3:25-3:45 BREAK / VISIT EXHIBITS 3:45-4:00 DNA Damage and Repair Philip Kantoff, MD 4:00-4:10 Gene-Oncogene Interactions Carlos Cordon-Cardo, MD, PhD 4:10-4:20 Prostate Cancer Heterogeneity Ganesh Palapattu, MD 4:20-4:30 Racial Disparities In Prostate Cancer Isaac Powell, MD 4:30-4:40 ADT and Castration Resistance William Oh, MD 4:40-4:55 Chemotherapy in Prostate Cancer Matthew Galsky, MD 4:55-5:05 PSMA Targeted Therapy Daniel Petrylak 5:05-5:15 Treatment of Primary Lesion in Metastatic Prostate Cancer Brian Francis Chapin, MD 5:15-5:25 Multimodal Treatment Paradigm in Early Metastatic Prostate Cancer Vincent Laudone, MD 5:25-5:40 Novel Approaches to Bone Metastasis in Prostate Cancer Alice Levine, MD 5:40-5:50 Drug Discovery And Development Of XTANDI: Lessons Learned From The Journey Lynn Seeley 5:50-6:00 Role of Prostate Cancer Foundation In Supporting Prostate Cancer Research Jonathan Simons, MD 6:00-6:15 Integration Of Imaging & Robotics: Robotic Platform Of 21st Century Gary Guthart, PhD 27 DAY - Friday, September BREAKOUT ROOM – Annenburg, 5th Floor SESSION I LOCALLY ADVANCED DISEASE Moderator: Kenneth Rosenzweig, MD 1:40-1:55 Role of RT For High Risk Disease Richard Stock, MD 1:55-2:10 Role of ADT with RT Michael Zelefsky, MD 2:10-2:25 Role of PSMA In Locally Advanced Disease Markus Hohenfellner, MD 2:25-2:35 Cyberknife Jonathan Haas, MD 2:35-2:45 IMRT Shawn Zimberg, MD 2:45-3:05 Debate: Cyberknife vs IMRT Moderator: Richard Stock Cyberknife: Jonathan Haas IMRT: Shawn Zimberg 3:05-3:15 Neoadjuvant Systemic Therapy Brian Francis Chapin, MD 3:15-3:35 BREAK / VISIT EXHIBITS SESSION II MORBIDITY AND QUALITY OF LIFE Moderator: Victor Nitti, MD 3:35-3:45 Penile Rehabilitation and Pharmacologic Treatment of ED Natan Bar-Chama, MD 3:45-4:05 Penile Implantation Post-RP Robert Valenzuela, MD 4:05-4:15 Urethral Stricture Management Rajveer Purohit, MD, FACS, MPH 4:15-4:25 Surgical Factors Influencing Early Continence Recovery Vincenzo Ficarra, MD 4:25-4:35 Post-RP Incontinence Management Victor Nitti, MD 4:35-4:55 Debate: Post-prostatectomy Incontinence: PFMT vs Early Sling/AUS Moderator: Victor Nitti, MD PFMT: Steve Kaplan, MD Early Sling/AUS: Neil Grafstein, MD 28 DAY - Friday, September 4:55-5:05 Treatment of LUTS Following RALP & RT Jerry Blaivas, MD 5:05-5:15 QoL and Lifestyle Changes - General Health Perspective Jefferey Mechanick, MD 5:15-5:25 QoL and Lifestyle Changes - Urology Perspective Philippa Cheetham, MD 5:25-5:35 Complications in Robotic Surgery Distant From The Surgical Site Daniel Gainsburg, MD 5:35-5:45 Peri-operative Safety Initiatives Amanda Rhee, MD 29 DAY - Saturday, September SESSION I KIDNEY CANCER - I Moderator: Michael Palese, Ashok Hemal, 7:00-7:05 Welcome and Program Overview Ketan Badani, MD 7:05-7:20 The Changing Face of Urologic Oncologic Surgery Over 15 Years: The Impact of Robotics Inderbir Gill, MD 7:20-7:35 Recovery of Renal Function After Radical and Partial Nephrectomy Steve Campbell, MD, PhD 7:35-7:50 Adjuvant Therapy in Renal Cell Carcinoma - Where are we in 2017? Robert Uzzo, MD, FACS 7:50-8:15 Debate: Small renal mass biopsy Pro: Jaime Landman, MD Con: Ronney Abaza, MD 8:15–8:40 Panel Discussion on Management of Renal Cancer Presenter: Chandru Sundaram, MD Panel: Jihad Kaouk, MD, Jaime Landman, MD, Ketan Badani, MD, Rene Sotelo, MD 8:40–9:05 Debate: Transperitoneal vs Retroperitoneal Partial Nephrectomy Transperitoneal: Jihad Kaouk, MD Retroperitoneal: James Porter, MD 9:05-9:15 BREAK / VISIT EXHIBITS SESSION II KIDNEY CANCER - II Moderators: Inderbir Gill, MD, Chandru Sundaram, MD 9:15–9:30 Tips and Tricks of Urinary Reconstruction Daniel Eun, MD 9:30–9:55 Debate: Partial vs Radical Nephrectomy for cT1b and cT2 Renal Masses with Normal Kidney Function Pro: Steve Campbell, MD, PhD Con: Robert Uzzo, MD 9:55-10:05 Update on Randomized Clinical Trial of the Use of Amniotic Membrane on Renal Preservation After Partial Nephrectomy Ketan Badani, MD 10:05–10:30 Challenging cases and management strategies Moderator: Rene Sotelo, MD Panel: Ketan Badani, MD, Daniel Eun, MD, Francesco Porpiglia, MD, James Porter, MD 30 DAY - Saturday, September 10:30-11:50 Live/Semi Surgery Surgeon: Ketan Badani, MD Panel: Inderbir Gill, MD Aneesh Srivastava, MD, Daniel Eun, MD, Ashok Hemal, MD 11:50–12:00 Complex robotic radical nephrectomy and IVC Thrombectomy Ronney Abaza, MD 12:00–1:00 LUNCH BREAK SESSION III KIDNEY CANCER - III Moderators: Nikhil Waingankar, MD, MPH, James Porter, MD 1:00-2:00 Live/Semi Live Surgery Surgeon: Ketan Badani, MD Panel: Jihad Kaouk, MD, Ronney Abaza, MD, Dipen Parekh, MD 2:00–2:10 Role of Cytoreductive Nephrectomy in the Targeted Therapy Era Che-Kai Tsao, MD 2:10-2:35 Debate: Management of cm Urothelial Carcinoma of Renal Pelvis Expert Panelist: Manoj Monga, MD Endoscopic Treatment: Mantu Gupta, MD Nephroureterectomy: Ashok Hemal, MD 2:35–2:45 BREAK / VISIT EXHIBITS SESSION IV BLADDER CANCER I Moderators: Khurshid Guru, MD,Reza Mehrazin, MD 2:45-2:50 Welcome Peter Wiklund, MD, PhD 2:50-3:05 Radical Cystectomy & “The Law Of Small Numbers” Mark Schoenberg, MD 3:05-3:20 Complications in Robotic Cystectomy Rene Sotelo, MD 3:20-3:35 RAZOR Trial Dipen Parekh, MD 3:35-3:50 ERAS Protocol Khurshid Guru, MD 3:50-4:50 Live/Semi-Live Case Surgeon: Peter Wiklund, MD, PhD Panel: Khurshid Guru, MD, Ketan Badani, MD, John Sfakianos, MD 4:50-5:15 Debate: Urinary Diversion in Robotic Radical Cystectomy Open: Dipen Parekh, MD Robotic: Khurshid Guru, MD 31 DAY - Saturday, September 5:15-5:30 Oncological Updates on RARC Justin Collins, MD 5:30-5:45 Outcomes After RARC and Aiming Points for the Future Peter Wiklund, MD, PhD 5:45-6:00 Should We Be Doing Extended LND During Radical Cystectomy John Sfakianos, MD 6:00-6:15 Adjuvant or Neoadjuvant Chemotherapy in Bladder Cancer Matthew Galsky, MD 6:15-6:20 Closing Remarks Ketan Badani, MD 32